Da en øget koncentration af HMG- CoA reduktase hæmmere kan forårsage myopati, herunder rhabdomyolyse, kan samtidig administration med Agenerase ikke anbefales.
Since increased concentrations of HMG-CoA reductase inhibitors may cause myopathy, including rhabdomyolysis, the combination of these medicinal products with Agenerase is not recommended.